(Q34546358)

2 August 2017

title

Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies (English)

1 reference

2 August 2017

1 reference

Stefan Vitko

1

1 reference

2 August 2017

Helio Tedesco

2

1 reference

2 August 2017

Josette Eris

3

1 reference

2 August 2017

Julio Pascual

4

1 reference

2 August 2017

John Whelchel

5

1 reference

2 August 2017

John C Magee

6

1 reference

2 August 2017

Scott Campbell

7

1 reference

2 August 2017

Giovanni Civati

8

1 reference

2 August 2017

Bernard Bourbigot

9

1 reference

2 August 2017

Gentil Alves Filho

10

1 reference

2 August 2017

John Leone

11

1 reference

2 August 2017

Valter Duro Garcia

12

1 reference

2 August 2017

Paolo Rigotti

13

1 reference

2 August 2017

Ronaldo Esmeraldo

14

1 reference

2 August 2017

Vincenzo Cambi

15

1 reference

2 August 2017

Tomas Haas

16

1 reference

2 August 2017

Annette Jappe

17

1 reference

2 August 2017

Peter Bernhardt

18

1 reference

2 August 2017

Johanna Geissler

19

1 reference

2 August 2017

Nathalie Cretin

20

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

American Journal of Transplantation

2 August 2017

published in

1 reference

2 August 2017

volume

4

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

626-635

1 reference

Post-transplant renal function in the first year predicts long-term kidney transplant survival

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00389.X

Early clinical experience with a novel rapamycin derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00389.X

SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00389.X

Suppression of acute rejection in allogeneic rat lung transplantation: a study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a microemulsion formulation of cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00389.X

Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to rat lung allograft recipients: potentiation of immunosuppressive efficacy and improvement of tolerability of staggered versus simultaneous treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00389.X

Population pharmacokinetics of everolimus in de novo renal transplant patients: impact of ethnicity and comedications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00389.X

Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00389.X

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00389.X

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00389.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00389.X

Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00389.X

Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00389.X

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00389.X

The Banff 97 working classification of renal allograft pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00389.X

10.1111/J.1600-6143.2004.00389.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference